Browsing: Pharmaceuticals

Recent coverage of the pipeline of new antibiotics (Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn, 11 March) is a timely reminder…

The pipeline of new drugs to fight superbugs remains “worryingly thin” and has shrunk by 35% in the last five years, experts have said, predicting the…

The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.Novo Nordisk’s…

The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in revenues this year owing to a push by Donald Trump to lower…

The UK has agreed to pay 25% more for new medicines by 2035 as part of a US-UK drug pricing deal that will cost an estimated…

The UK science minister has said officials are “working day and night” trying to resolve the standoff with big pharmaceutical companies over drug pricing.Speaking to industry…

‘We want to see more investment flow to Britain,” the chancellor, Rachel Reeves, urged of big pharmaceutical companies this month, as she indicated that the government…

The chair of Wegovy maker Novo Nordisk, Helge Lund, and six other board members are stepping down in a surprise shake-up, after a row with the…

While the chief executive of Eli Lilly may lament the UK’s drug prices (UK is ‘worst country in Europe’ for drug prices, says Mounjaro maker, 24…

Ministers are preparing to raise the amount the NHS pays pharmaceutical firms for medicines by up to 25% after weeks of intensive talks with the Donald…